Literature DB >> 26917237

Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.

Annegret Kathagen-Buhmann1, Alexander Schulte1, Jonathan Weller1, Mareike Holz1, Christel Herold-Mende1, Rainer Glass1, Katrin Lamszus2.   

Abstract

BACKGROUND: The dichotomy between glioblastoma cell migration and proliferation is regulated by various parameters including oxygen tension. In glioblastoma stem-like cells, hypoxia induces downregulation of pentose phosphate pathway (PPP) enzymes and a flux shift towards glycolysis. We investigated whether the 2 parallel glucose metabolic pathways are intrinsically linked with cell function and whether these pathways are mechanistically involved in regulating functional programs.
METHODS: Enzyme expression, migration, and proliferation under hypoxia were studied in multiple cell types. Rapidly and slowly dividing or migrating glioblastoma cells were separated, and enzyme profiles were compared. Glucose-6-phosphate dehydrogenase (G6PD) and Aldolase C (ALDOC), the most strongly inversely regulated PPP and glycolysis enzymes, were knocked down by short hairpin RNA.
RESULTS: Hypoxia caused downregulation of PPP enzymes and upregulation of glycolysis enzymes in a broad spectrum of cancer and nonneoplastic cells and consistently stimulated migration while reducing proliferation. PPP enzyme expression was increased in rapidly dividing glioblastoma cells, whereas glycolysis enzymes were decreased. Conversely, glycolysis enzymes were elevated in migrating cells, whereas PPP enzymes were diminished. Knockdown of G6PD reduced glioblastoma cell proliferation, whereas ALDOC knockdown decreased migration. Enzyme inhibitors had similar effects. G6PD knockdown in a highly proliferative but noninvasive glioblastoma cell line resulted in prolonged survival of mice with intracerebral xenografts, whereas ALDOC knockdown shortened survival. In a highly invasive glioblastoma xenograft model, tumor burden was unchanged by either knockdown.
CONCLUSIONS: Cell function and metabolic state are coupled independently of hypoxia, and glucose metabolic pathways are causatively involved in regulating "go or grow" cellular programs.
© The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  glioma; glycolysis; invasion; metabolism; pentose phosphate pathway

Mesh:

Substances:

Year:  2016        PMID: 26917237      PMCID: PMC4998991          DOI: 10.1093/neuonc/now024

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  27 in total

Review 1.  Glycolytic enzyme inhibitors in cancer treatment.

Authors:  Roberto Scatena; Patrizia Bottoni; Alessandro Pontoglio; Lucia Mastrototaro; Bruno Giardina
Journal:  Expert Opin Investig Drugs       Date:  2008-10       Impact factor: 6.206

2.  A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.

Authors:  Tobias Martens; Nils-Ole Schmidt; Carmen Eckerich; Regina Fillbrandt; Mark Merchant; Ralph Schwall; Manfred Westphal; Katrin Lamszus
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

3.  Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

Authors:  P Kunkel; U Ulbricht; P Bohlen; M A Brockmann; R Fillbrandt; D Stavrou; M Westphal; K Lamszus
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

Review 4.  The hypoxic tumor microenvironment: A driving force for breast cancer progression.

Authors:  Gregg L Semenza
Journal:  Biochim Biophys Acta       Date:  2015-06-14

5.  Glycolysis as primary energy source in tumor cell chemotaxis.

Authors:  M E Beckner; M L Stracke; L A Liotta; E Schiffmann
Journal:  J Natl Cancer Inst       Date:  1990-12-05       Impact factor: 13.506

6.  Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.

Authors:  Olivier Keunen; Mikael Johansson; Anaïs Oudin; Morgane Sanzey; Siti A Abdul Rahim; Fred Fack; Frits Thorsen; Torfinn Taxt; Michal Bartos; Radovan Jirik; Hrvoje Miletic; Jian Wang; Daniel Stieber; Linda Stuhr; Ingrid Moen; Cecilie Brekke Rygh; Rolf Bjerkvig; Simone P Niclou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

7.  Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanisms.

Authors:  Martin Zamykal; Tobias Martens; Jakob Matschke; Hauke S Günther; Annegret Kathagen; Alexander Schulte; Regina Peters; Manfred Westphal; Katrin Lamszus
Journal:  Neuro Oncol       Date:  2014-12-27       Impact factor: 12.300

8.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Authors:  John M Heddleston; Zhizhong Li; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

9.  Ku70/80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts.

Authors:  U Kasten; N Plottner; J Johansen; J Overgaard; E Dikomey
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

10.  CD133 is a marker of bioenergetic stress in human glioma.

Authors:  Corinne E Griguer; Claudia R Oliva; Eric Gobin; Pascale Marcorelles; Dale J Benos; Jack R Lancaster; G Yancey Gillespie
Journal:  PLoS One       Date:  2008-11-05       Impact factor: 3.240

View more
  49 in total

1.  YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells.

Authors:  Jixiang Chen; Yaocheng Sun; Xiao Xu; Dawei Wang; Junbo He; Hailang Zhou; Ying Lu; Jian Zeng; Fengyi Du; Aihua Gong; Min Xu
Journal:  Cell Cycle       Date:  2017-11-14       Impact factor: 4.534

2.  Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells.

Authors:  Filipa Lopes-Coelho; Carolina Nunes; Sofia Gouveia-Fernandes; Rita Rosas; Fernanda Silva; Paula Gameiro; Tânia Carvalho; Maria Gomes da Silva; José Cabeçadas; Sérgio Dias; Luís G Gonçalves; Jacinta Serpa
Journal:  Oncotarget       Date:  2017-08-16

3.  Investigation of solid tumor progression with account of proliferation/migration dichotomy via Darwinian mathematical model.

Authors:  Maxim Kuznetsov; Andrey Kolobov
Journal:  J Math Biol       Date:  2019-10-01       Impact factor: 2.259

4.  The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.

Authors:  Annegret Kathagen-Buhmann; Cecile L Maire; Jonathan Weller; Alexander Schulte; Jakob Matschke; Mareike Holz; Keith L Ligon; Markus Glatzel; Manfred Westphal; Katrin Lamszus
Journal:  Neuro Oncol       Date:  2018-11-12       Impact factor: 12.300

5.  Integrating Mathematical Modeling with High-Throughput Imaging Explains How Polyploid Populations Behave in Nutrient-Sparse Environments.

Authors:  Gregory J Kimmel; Mark Dane; Laura M Heiser; Philipp M Altrock; Noemi Andor
Journal:  Cancer Res       Date:  2020-09-16       Impact factor: 12.701

Review 6.  The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.

Authors:  Catherine J Libby; Anh Nhat Tran; Sarah E Scott; Corinne Griguer; Anita B Hjelmeland
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 10.680

Review 7.  The bioenergetics of neuronal morphogenesis and regeneration: Frontiers beyond the mitochondrion.

Authors:  Gianluca Gallo
Journal:  Dev Neurobiol       Date:  2020-09-27       Impact factor: 3.964

8.  Measurement of 13 C turnover into glutamate and glutamine pools in brain tumor patients.

Authors:  Kumar Pichumani; Tomoyuki Mashimo; Vamsidhara Vemireddy; Omkar B Ijare; Bruce E Mickey; Craig R Malloy; Isaac Marin-Valencia; David S Baskin; Robert M Bachoo; Elizabeth A Maher
Journal:  FEBS Lett       Date:  2017-10-27       Impact factor: 4.124

Review 9.  Hans Joachim Scherer: an under-recognized pioneer of glioma research in Belgium.

Authors:  Gilles Reuter; Arnaud Lombard; Eric Suero Molina; Felix Scholtes; Elettra Bianchi
Journal:  Acta Neurol Belg       Date:  2021-05-17       Impact factor: 2.396

Review 10.  The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer.

Authors:  Lakshmipathi Vadlakonda; Meera Indracanti; Suresh K Kalangi; B Meher Gayatri; Navya G Naidu; Aramati B M Reddy
Journal:  J Diabetes Metab Disord       Date:  2020-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.